NeoGraph Analytics
Healthcare TechnologyNorth America2023 – 2032

Circadian Rhythm Sleep Disorder Market Size, Share and Trends Analysis

Global Circadian Rhythm Sleep Disorder market valued at USD 1.2B in 2023, projected to reach USD 2.8B by 2032 with 10.2% CAGR. Explore key segments, regional dynamics, and major players.

Revenue, 2023

$1.2B

Forecast, 2032

$2.8B

CAGR, 2024-2032

10.2%

Report Coverage

North America

Code: circadian-rhythm-sleep-disorder-marketPublished: 2026Pages: 150+Format: PDF + Excel
01

Market Overview

The Circadian Rhythm Sleep Disorder market is experiencing robust growth driven by rising awareness of sleep health issues and technological innovations, with a projected CAGR of 10.2% from 2023 to 2032.

Market Stage

Early growth

Adoption Level

Growing

Key Trends

Integration of AI in sleep monitoring devicesIncreasing adoption of digital CBT platformsRise of personalized light therapy protocolsGrowing telehealth integration for sleep disorder management
02

Market Forecast & Data

Market Growth Forecast
2024-2032 · CAGR 10.2%

Base Year (2023)

$1.3B

Forecast (2032)

$2.8B

CAGR (2024-2032)

10.2%

Regional Market Analysis
Market share and growth rate by region

North America

#1
Share: 42.3%CAGR: 9.8%

Largest market: United States

Europe

#2
Share: 32.1%CAGR: 8.5%

Largest market: Germany

03

Market Dynamics

  • Rising shift work population globally
  • Increased awareness of sleep health consequences
  • Advancements in wearable technology
  • Digital health reimbursement policies
04

Market Segmentation

By Application

  • Delayed Sleep Phase Disorder
  • Advanced Sleep Phase Disorder
  • Shift Work Sleep Disorder
  • Jet Lag Syndrome

By End User

  • Hospitals & Clinics
  • Home Care Settings
  • Primary Care Physicians
  • Specialized Sleep Centers
05

Regional Analysis

1

North America

Lead: United States
CAGR: 9.8%Share: 42.3%

Dominates the market due to high healthcare expenditure and strong pharmaceutical innovation, with the US accounting for 85% of regional share.

2

Europe

Lead: Germany
CAGR: 8.5%Share: 32.1%

Germany leads European adoption through robust health insurance coverage for sleep diagnostics.

3

Asia Pacific

Lead: Japan
CAGR: 12.3%Share: 25.6%

Rapid growth driven by increasing urbanization and healthcare infrastructure development in China and Japan.

Country-Level Analysis

CountryShareGrowth
United States
35.7%
+10.1%
Germany
14.2%
+8.9%
Japan
11.8%
+11.5%
06

Competitive Landscape

P

Philips Healthcare

Netherlands

Leader60B

Developing integrated sleep management solutions combining wearables and digital therapeutics

Sleep and Circadian Health PlatformSmart Lighting Solutions
R

ResMed

Australia

Leader5.2B

Expanding respiratory care platform into circadian health with smart lighting solutions

ResMed SmartSleepCircadian Light Therapy Systems
C

Circadia Health

USA

Challenger

Pioneering AI-driven digital CBT for circadian disorders

S

Somnus Medical

USA

Follower

Specializing in prescription melatonin agonists for shift work disorder

W

Withings

France

Follower

Leading wearable manufacturer with circadian sleep tracking features

07

Recent Developments

25
2025Philips Healthcare

FDA clearance for AI-powered circadian rhythm adjustment in sleep apnea therapy

24
2024Circadia Health

Partnership with Teladoc Health for integrated digital CBT delivery

24
2024ResMed

Launch of circadian-aware sleep tracking wearables with EHR integration

23
2023Somnus Medical

FDA approval for novel melatonin agonist targeting shift work disorder

08

Regulatory Landscape

FDA approval requirements for digital therapeutics as medical devicesEMA guidelines for sleep disorder diagnosticsWHO recommendations for circadian health management
09

Frequently Asked Questions

The market size was USD 1.2 billion in 2023 and is projected to reach USD 2.8 billion by 2032.
The market is expected to grow at a CAGR of 10.2% from 2024 to 2032.
Light therapy devices currently dominate with 35.2% market share.
Asia Pacific is the fastest-growing region with a CAGR of 12.3% through 2032.